Shaw; Duncan
Patent Applications and Registrations
Patent applications and USPTO patent grants for Shaw; Duncan.The latest application filed is for "1,2,4-oxadiazole derivatives as liver x receptor agonists".
- Shaw; Duncan - Sharon MA
- Shaw; Duncan - West Sussex N/A GB
- Shaw; Duncan - Horsham GB
- Shaw; Duncan - Billingshurst N/A GB
- Shaw; Duncan - Sussex GB
- Shaw, Duncan - Bishops Stortford GB
| Patent | Date |
|---|---|
| 1,2,4-oxadiazole derivatives as liver X receptor agonists Grant 11,427,586 - Boss , et al. August 30, 2 | 2022-08-30 |
| 1,2,4-oxadiazole Derivatives As Liver X Receptor Agonists App 20220064164 - BOSS; Kelly D. ; et al. | 2022-03-03 |
| N-(pyridin-2-ylsulfonyl)cyclopropanecarboxamide Derivatives and their Use in the Treatment of Disease App 20220033407 - Azimioara; Mihai D. ; et al. | 2022-02-03 |
| Carboxamide Derivatives App 20210052554 - BALA; Kamlesh Jagdis ; et al. | 2021-02-25 |
| Carboxamide Derivatives App 20200268718 - BALA; Kamlesh Jagdis ; et al. | 2020-08-27 |
| Carboxamide Derivatives App 20190381011 - BALA; Kamlesh Jagdis ; et al. | 2019-12-19 |
| Carboxamide derivatives Grant 10,195,181 - Bala , et al. Fe | 2019-02-05 |
| Bicyclic heterocycle derivatives for the treatment of pulmonary arterial hypertension Grant 9,751,876 - Bruce , et al. September 5, 2 | 2017-09-05 |
| Carboxamide Derivatives App 20170014388 - BALA; Kamlesh Jagdis ; et al. | 2017-01-19 |
| Carboxamide derivatives Grant 9,403,810 - Bala , et al. August 2, 2 | 2016-08-02 |
| Carboxamide Derivatives App 20150329529 - BALA; Kamlesh Jagdis ; et al. | 2015-11-19 |
| Imidazo-pyridine derivatives as activin-like receptor kinase (ALK4 or ALK5) inhibitors Grant 9,079,897 - Leblanc , et al. July 14, 2 | 2015-07-14 |
| Salt forms of bicyclic heterocyclic derivatives Grant 9,073,921 - Bruce , et al. July 7, 2 | 2015-07-07 |
| Bicyclic Heterocycle Derivatives For The Treatment Of Pulmonary Arterial Hypertension App 20150025059 - Bruce; Ian ; et al. | 2015-01-22 |
| Bicyclic heterocycle derivatives for the treatment of pulmonary arterial hypertension Grant 8,883,819 - Bruce , et al. November 11, 2 | 2014-11-11 |
| Salt Forms Of Bicyclic Heterocyclic Derivatives App 20140249177 - BRUCE; Ian ; et al. | 2014-09-04 |
| Compounds And Compositions As Pdgfr Kinase Inhibitors App 20140206682 - Liang; Fang ; et al. | 2014-07-24 |
| Bicyclic Heterocycle Derivatives For The Treatment Of Pulmonary Arterial Hypertension App 20130237519 - Bruce; Ian ; et al. | 2013-09-12 |
| Organic compounds Grant 8,367,662 - Shaw , et al. February 5, 2 | 2013-02-05 |
| Pyrimidine derivatives as alk-5 inhibitors Grant 7,989,458 - Leblanc , et al. August 2, 2 | 2011-08-02 |
| Imidazo-Pyridine Derivatives as Activin-Like Receptor Kinase (ALK4 or ALK5) Inhibitors App 20110060004 - Leblanc; Catherine ; et al. | 2011-03-10 |
| Organic Compounds App 20100210641 - Shaw; Duncan ; et al. | 2010-08-19 |
| Heterocyclic compounds as antiinflammatory agents App 20100041662 - Ferrand; Sandrine ; et al. | 2010-02-18 |
| Pyrimidine derivatives as alk-5 Inhibitors App 20090209539 - Leblanc; Catherine ; et al. | 2009-08-20 |
| Tetrahydropyran derivatives and their use as therapeutic agents App 20040254184 - Castro Pineiro, Jose Luis ; et al. | 2004-12-16 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 